The global market for Pathological Lung Models was valued at US$ 279 million in the year 2024 and is projected to reach a revised size of US$ 507 million by 2031, growing at a CAGR of 9.0% during the forecast period.

Pathological Lung Models Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pathological Lung Models competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

In 2024, global Pathological Lung Models production reached approximately 1.55 M units, with an average global market price of around US$ 180 per unit.Pathological lung models are specialized anatomical teaching and demonstration tools that accurately replicate human lung structures affected by various diseases or pathological conditions. Unlike standard anatomical lung models, these models visually present disease-specific changes, such as inflammation, tumors, fibrosis, emphysema, pneumonia, tuberculosis, pulmonary edema, or cancerous growths. They are designed to help students, clinicians, and patients understand how pathological processes alter normal lung anatomy and function.

Gross Profit Margin Level

The overall gross profit margin of pathological lung models is in the mid-to-high range, approximately 50%–68%, significantly higher than that of general basic anatomical models. Its high profit structure mainly stems from the high degree of product specialization, a large proportion of R&D and design costs, while raw material and assembly costs are relatively limited. Pathological lung models are typically made of high-precision silicone, resin, or 3D-printed composite materials. Some high-end products feature transparent layered structures, detachable lesion modules, or AR digital interactive functions, making their unit price much higher than ordinary lung models. International brands, relying on their comprehensive product portfolios and global education channels, can maintain stable high gross profit margins; while OEMs and educational equipment manufacturers in Asia, through large-scale production and local sales networks, achieve profit margins of approximately 35%–45% at mid-range prices. Overall, pathological lung models, due to their combined educational function and medical demonstration value, have become one of the most profitable product categories in the medical simulation teaching sub-market.

Key Drivers

The core drivers of growth in the pathological lung model market mainly come from four trends: the upgrading of medical education systems, the rising demand for disease prevention and control publicity, the popularization of digital simulation and 3D printing technologies, and the globalization of medical training. First, with the improvement of global medical school and nursing education standards, pathology teaching models are widely incorporated into clinical teaching and diagnostic training courses to help students understand the morphological characteristics and clinical manifestations of lung diseases. Second, the high incidence of respiratory diseases (such as COPD, lung cancer, and tuberculosis) worldwide has driven the demand for model applications in health education by public health institutions and pharmaceutical companies. Third, the development of 3D printing and multi-material molding technologies has significantly improved the realism and personalized production capabilities of models, enabling more manufacturers to develop high-precision pathology models at a lower cost. Finally, the internationalization of medical education and the rise of remote simulation teaching have also driven the continuous procurement of highly visualized, interactive pathological lung models in the global market, thus forming a long-term and stable growth driver for the industry.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pathological Lung Models, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pathological Lung Models.

The Pathological Lung Models market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pathological Lung Models market comprehensively. Regional market sizes, concerning products by Type, by Application, by Disease Type and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pathological Lung Models manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Disease Type and by regions.

Scope of Pathological Lung Models Market Report

Report Metric	Details
Report Name	Pathological Lung Models Market
Accounted market size in year	US$ 279 million
Forecasted market size in 2031	US$ 507 million
CAGR	9.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Silicone Models Biocomposite Material Models Others
Segment by Disease Type	Chronic Diseases Oncology Others
Segment by Detail Level	Low Fidelity High Fidelity
Segment by Use	Teaching Clinical Drills
Segment by Application	Hospitals Specialist Clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	3B Scientific, Lonza Group, Epithelix, GPI Anatomicals, Emulate, Insphero, MatTek Corporation, TissUse, CN Bio Innovations, Eisco Labs, Axis Scientific, HeineScientific
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pathological Lung Models manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pathological Lung Models in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Pathological Lung Models Market growing?

Ans: The Pathological Lung Models Market witnessing a CAGR of 9.0% during the forecast period 2025-2031.

What is the Pathological Lung Models Market size in 2031?

Ans: The Pathological Lung Models Market size in 2031 will be US$ 507 million.

Who are the main players in the Pathological Lung Models Market report?

Ans: The main players in the Pathological Lung Models Market are 3B Scientific, Lonza Group, Epithelix, GPI Anatomicals, Emulate, Insphero, MatTek Corporation, TissUse, CN Bio Innovations, Eisco Labs, Axis Scientific, HeineScientific

What are the Application segmentation covered in the Pathological Lung Models Market report?

Ans: The Applications covered in the Pathological Lung Models Market report are Hospitals, Specialist Clinics, Others

What are the Type segmentation covered in the Pathological Lung Models Market report?

Ans: The Types covered in the Pathological Lung Models Market report are Chronic Diseases, Oncology, Others

1 Pathological Lung Models Market Overview

1.1 Product Definition

1.2 Pathological Lung Models by Type

1.2.1 Global Pathological Lung Models Market Value Comparison by Type (2024 VS 2031)

1.2.2 Silicone Models

1.2.3 Biocomposite Material Models

1.2.4 Others

1.3 Pathological Lung Models by Disease Type

1.3.1 Global Pathological Lung Models Market Value Comparison by Disease Type: 2024 VS 2031

1.3.2 Chronic Diseases

1.3.3 Oncology

1.3.4 Others

1.4 Pathological Lung Models by Detail Level

1.4.1 Global Pathological Lung Models Market Value Comparison by Detail Level: 2024 VS 2031

1.4.2 Low Fidelity

1.4.3 High Fidelity

1.5 Pathological Lung Models by Use

1.5.1 Global Pathological Lung Models Market Value Comparison by Use: 2024 VS 2031

1.5.2 Teaching

1.5.3 Clinical Drills

1.6 Pathological Lung Models by Application

1.6.1 Global Pathological Lung Models Market Value by Application (2024 VS 2031)

1.6.2 Hospitals

1.6.3 Specialist Clinics

1.6.4 Others

1.7 Global Pathological Lung Models Market Size Estimates and Forecasts

1.7.1 Global Pathological Lung Models Revenue 2020-2031

1.7.2 Global Pathological Lung Models Sales 2020-2031

1.7.3 Global Pathological Lung Models Market Average Price (2020-2031)

1.8 Assumptions and Limitations

2 Pathological Lung Models Market Competition by Manufacturers

2.1 Global Pathological Lung Models Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pathological Lung Models Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pathological Lung Models Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pathological Lung Models, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pathological Lung Models, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pathological Lung Models, Product Type & Application

2.7 Global Key Manufacturers of Pathological Lung Models, Date of Enter into This Industry

2.8 Global Pathological Lung Models Market Competitive Situation and Trends

2.8.1 Global Pathological Lung Models Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pathological Lung Models Players Market Share by Revenue

2.8.3 Global Pathological Lung Models Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pathological Lung Models Market Scenario by Region

3.1 Global Pathological Lung Models Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pathological Lung Models Sales by Region: 2020-2031

3.2.1 Global Pathological Lung Models Sales by Region: 2020-2025

3.2.2 Global Pathological Lung Models Sales by Region: 2026-2031

3.3 Global Pathological Lung Models Revenue by Region: 2020-2031

3.3.1 Global Pathological Lung Models Revenue by Region: 2020-2025

3.3.2 Global Pathological Lung Models Revenue by Region: 2026-2031

3.4 North America Pathological Lung Models Market Facts & Figures by Country

3.4.1 North America Pathological Lung Models Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pathological Lung Models Sales by Country (2020-2031)

3.4.3 North America Pathological Lung Models Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Pathological Lung Models Market Facts & Figures by Country

3.5.1 Europe Pathological Lung Models Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pathological Lung Models Sales by Country (2020-2031)

3.5.3 Europe Pathological Lung Models Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pathological Lung Models Market Facts & Figures by Region

3.6.1 Asia Pacific Pathological Lung Models Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pathological Lung Models Sales by Region (2020-2031)

3.6.3 Asia Pacific Pathological Lung Models Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Pathological Lung Models Market Facts & Figures by Country

3.7.1 Latin America Pathological Lung Models Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pathological Lung Models Sales by Country (2020-2031)

3.7.3 Latin America Pathological Lung Models Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Pathological Lung Models Market Facts & Figures by Country

3.8.1 Middle East and Africa Pathological Lung Models Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pathological Lung Models Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pathological Lung Models Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Pathological Lung Models Sales by Type (2020-2031)

4.1.1 Global Pathological Lung Models Sales by Type (2020-2025)

4.1.2 Global Pathological Lung Models Sales by Type (2026-2031)

4.1.3 Global Pathological Lung Models Sales Market Share by Type (2020-2031)

4.2 Global Pathological Lung Models Revenue by Type (2020-2031)

4.2.1 Global Pathological Lung Models Revenue by Type (2020-2025)

4.2.2 Global Pathological Lung Models Revenue by Type (2026-2031)

4.2.3 Global Pathological Lung Models Revenue Market Share by Type (2020-2031)

4.3 Global Pathological Lung Models Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pathological Lung Models Sales by Application (2020-2031)

5.1.1 Global Pathological Lung Models Sales by Application (2020-2025)

5.1.2 Global Pathological Lung Models Sales by Application (2026-2031)

5.1.3 Global Pathological Lung Models Sales Market Share by Application (2020-2031)

5.2 Global Pathological Lung Models Revenue by Application (2020-2031)

5.2.1 Global Pathological Lung Models Revenue by Application (2020-2025)

5.2.2 Global Pathological Lung Models Revenue by Application (2026-2031)

5.2.3 Global Pathological Lung Models Revenue Market Share by Application (2020-2031)

5.3 Global Pathological Lung Models Price by Application (2020-2031)

6 Key Companies Profiled

6.1 3B Scientific

6.1.1 3B Scientific Company Information

6.1.2 3B Scientific Description and Business Overview

6.1.3 3B Scientific Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.1.4 3B Scientific Pathological Lung Models Product Portfolio

6.1.5 3B Scientific Recent Developments/Updates

6.2 Lonza Group

6.2.1 Lonza Group Company Information

6.2.2 Lonza Group Description and Business Overview

6.2.3 Lonza Group Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Lonza Group Pathological Lung Models Product Portfolio

6.2.5 Lonza Group Recent Developments/Updates

6.3 Epithelix

6.3.1 Epithelix Company Information

6.3.2 Epithelix Description and Business Overview

6.3.3 Epithelix Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Epithelix Pathological Lung Models Product Portfolio

6.3.5 Epithelix Recent Developments/Updates

6.4 GPI Anatomicals

6.4.1 GPI Anatomicals Company Information

6.4.2 GPI Anatomicals Description and Business Overview

6.4.3 GPI Anatomicals Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.4.4 GPI Anatomicals Pathological Lung Models Product Portfolio

6.4.5 GPI Anatomicals Recent Developments/Updates

6.5 Emulate

6.5.1 Emulate Company Information

6.5.2 Emulate Description and Business Overview

6.5.3 Emulate Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Emulate Pathological Lung Models Product Portfolio

6.5.5 Emulate Recent Developments/Updates

6.6 Insphero

6.6.1 Insphero Company Information

6.6.2 Insphero Description and Business Overview

6.6.3 Insphero Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Insphero Pathological Lung Models Product Portfolio

6.6.5 Insphero Recent Developments/Updates

6.7 MatTek Corporation

6.7.1 MatTek Corporation Company Information

6.7.2 MatTek Corporation Description and Business Overview

6.7.3 MatTek Corporation Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.7.4 MatTek Corporation Pathological Lung Models Product Portfolio

6.7.5 MatTek Corporation Recent Developments/Updates

6.8 TissUse

6.8.1 TissUse Company Information

6.8.2 TissUse Description and Business Overview

6.8.3 TissUse Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.8.4 TissUse Pathological Lung Models Product Portfolio

6.8.5 TissUse Recent Developments/Updates

6.9 CN Bio Innovations

6.9.1 CN Bio Innovations Company Information

6.9.2 CN Bio Innovations Description and Business Overview

6.9.3 CN Bio Innovations Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.9.4 CN Bio Innovations Pathological Lung Models Product Portfolio

6.9.5 CN Bio Innovations Recent Developments/Updates

6.10 Eisco Labs

6.10.1 Eisco Labs Company Information

6.10.2 Eisco Labs Description and Business Overview

6.10.3 Eisco Labs Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Eisco Labs Pathological Lung Models Product Portfolio

6.10.5 Eisco Labs Recent Developments/Updates

6.11 Axis Scientific

6.11.1 Axis Scientific Company Information

6.11.2 Axis Scientific Description and Business Overview

6.11.3 Axis Scientific Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Axis Scientific Pathological Lung Models Product Portfolio

6.11.5 Axis Scientific Recent Developments/Updates

6.12 HeineScientific

6.12.1 HeineScientific Company Information

6.12.2 HeineScientific Description and Business Overview

6.12.3 HeineScientific Pathological Lung Models Sales, Revenue and Gross Margin (2020-2025)

6.12.4 HeineScientific Pathological Lung Models Product Portfolio

6.12.5 HeineScientific Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pathological Lung Models Industry Chain Analysis

7.2 Pathological Lung Models Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pathological Lung Models Production Mode & Process Analysis

7.4 Pathological Lung Models Sales and Marketing

7.4.1 Pathological Lung Models Sales Channels

7.4.2 Pathological Lung Models Distributors

7.5 Pathological Lung Models Customer Analysis

8 Pathological Lung Models Market Dynamics

8.1 Pathological Lung Models Industry Trends

8.2 Pathological Lung Models Market Drivers

8.3 Pathological Lung Models Market Challenges

8.4 Pathological Lung Models Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Pathological Lung Models Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pathological Lung Models Market Value by Disease Type, (US$ Million) & (2024 VS 2031)

Table 3. Global Pathological Lung Models Market Value by Detail Level, (US$ Million) & (2024 VS 2031)

Table 4. Global Pathological Lung Models Market Value by Use, (US$ Million) & (2024 VS 2031)

Table 5. Global Pathological Lung Models Market Value by Application (2024 VS 2031) & (US$ Million)

Table 6. Global Pathological Lung Models Market Competitive Situation by Manufacturers in 2024

Table 7. Global Pathological Lung Models Sales (K Units) of Key Manufacturers (2020-2025)

Table 8. Global Pathological Lung Models Sales Market Share by Manufacturers (2020-2025)

Table 9. Global Pathological Lung Models Revenue (US$ Million) by Manufacturers (2020-2025)

Table 10. Global Pathological Lung Models Revenue Share by Manufacturers (2020-2025)

Table 11. Global Market Pathological Lung Models Average Price (K Units) of Key Manufacturers (2020-2025)

Table 12. Global Key Players of Pathological Lung Models, Industry Ranking, 2022 VS 2023 VS 2024

Table 13. Global Key Manufacturers of Pathological Lung Models, Manufacturing Sites & Headquarters

Table 14. Global Key Manufacturers of Pathological Lung Models, Product Type & Application

Table 15. Global Key Manufacturers of Pathological Lung Models, Date of Enter into This Industry

Table 16. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Pathological Lung Models by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Lung Models as of 2024)

Table 18. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 19. Global Pathological Lung Models Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 20. Global Pathological Lung Models Sales by Region (2020-2025) & (K Units)

Table 21. Global Pathological Lung Models Sales Market Share by Region (2020-2025)

Table 22. Global Pathological Lung Models Sales by Region (2026-2031) & (K Units)

Table 23. Global Pathological Lung Models Sales Market Share by Region (2026-2031)

Table 24. Global Pathological Lung Models Revenue by Region (2020-2025) & (US$ Million)

Table 25. Global Pathological Lung Models Revenue Market Share by Region (2020-2025)

Table 26. Global Pathological Lung Models Revenue by Region (2026-2031) & (US$ Million)

Table 27. Global Pathological Lung Models Revenue Market Share by Region (2026-2031)

Table 28. North America Pathological Lung Models Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. North America Pathological Lung Models Sales by Country (2020-2025) & (K Units)

Table 30. North America Pathological Lung Models Sales by Country (2026-2031) & (K Units)

Table 31. North America Pathological Lung Models Revenue by Country (2020-2025) & (US$ Million)

Table 32. North America Pathological Lung Models Revenue by Country (2026-2031) & (US$ Million)

Table 33. Europe Pathological Lung Models Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 34. Europe Pathological Lung Models Sales by Country (2020-2025) & (K Units)

Table 35. Europe Pathological Lung Models Sales by Country (2026-2031) & (K Units)

Table 36. Europe Pathological Lung Models Revenue by Country (2020-2025) & (US$ Million)

Table 37. Europe Pathological Lung Models Revenue by Country (2026-2031) & (US$ Million)

Table 38. Asia Pacific Pathological Lung Models Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 39. Asia Pacific Pathological Lung Models Sales by Region (2020-2025) & (K Units)

Table 40. Asia Pacific Pathological Lung Models Sales by Region (2026-2031) & (K Units)

Table 41. Asia Pacific Pathological Lung Models Revenue by Region (2020-2025) & (US$ Million)

Table 42. Asia Pacific Pathological Lung Models Revenue by Region (2026-2031) & (US$ Million)

Table 43. Latin America Pathological Lung Models Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Latin America Pathological Lung Models Sales by Country (2020-2025) & (K Units)

Table 45. Latin America Pathological Lung Models Sales by Country (2026-2031) & (K Units)

Table 46. Latin America Pathological Lung Models Revenue by Country (2020-2025) & (US$ Million)

Table 47. Latin America Pathological Lung Models Revenue by Country (2026-2031) & (US$ Million)

Table 48. Middle East and Africa Pathological Lung Models Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Middle East and Africa Pathological Lung Models Sales by Country (2020-2025) & (K Units)

Table 50. Middle East and Africa Pathological Lung Models Sales by Country (2026-2031) & (K Units)

Table 51. Middle East and Africa Pathological Lung Models Revenue by Country (2020-2025) & (US$ Million)

Table 52. Middle East and Africa Pathological Lung Models Revenue by Country (2026-2031) & (US$ Million)

Table 53. Global Pathological Lung Models Sales (K Units) by Type (2020-2025)

Table 54. Global Pathological Lung Models Sales (K Units) by Type (2026-2031)

Table 55. Global Pathological Lung Models Sales Market Share by Type (2020-2025)

Table 56. Global Pathological Lung Models Sales Market Share by Type (2026-2031)

Table 57. Global Pathological Lung Models Revenue (US$ Million) by Type (2020-2025)

Table 58. Global Pathological Lung Models Revenue (US$ Million) by Type (2026-2031)

Table 59. Global Pathological Lung Models Revenue Market Share by Type (2020-2025)

Table 60. Global Pathological Lung Models Revenue Market Share by Type (2026-2031)

Table 61. Global Pathological Lung Models Price (K Units) by Type (2020-2025)

Table 62. Global Pathological Lung Models Price (K Units) by Type (2026-2031)

Table 63. Global Pathological Lung Models Sales (K Units) by Application (2020-2025)

Table 64. Global Pathological Lung Models Sales (K Units) by Application (2026-2031)

Table 65. Global Pathological Lung Models Sales Market Share by Application (2020-2025)

Table 66. Global Pathological Lung Models Sales Market Share by Application (2026-2031)

Table 67. Global Pathological Lung Models Revenue (US$ Million) by Application (2020-2025)

Table 68. Global Pathological Lung Models Revenue (US$ Million) by Application (2026-2031)

Table 69. Global Pathological Lung Models Revenue Market Share by Application (2020-2025)

Table 70. Global Pathological Lung Models Revenue Market Share by Application (2026-2031)

Table 71. Global Pathological Lung Models Price (K Units) by Application (2020-2025)

Table 72. Global Pathological Lung Models Price (K Units) by Application (2026-2031)

Table 73. 3B Scientific Company Information

Table 74. 3B Scientific Description and Business Overview

Table 75. 3B Scientific Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 76. 3B Scientific Pathological Lung Models Product

Table 77. 3B Scientific Recent Developments/Updates

Table 78. Lonza Group Company Information

Table 79. Lonza Group Description and Business Overview

Table 80. Lonza Group Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 81. Lonza Group Pathological Lung Models Product

Table 82. Lonza Group Recent Developments/Updates

Table 83. Epithelix Company Information

Table 84. Epithelix Description and Business Overview

Table 85. Epithelix Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 86. Epithelix Pathological Lung Models Product

Table 87. Epithelix Recent Developments/Updates

Table 88. GPI Anatomicals Company Information

Table 89. GPI Anatomicals Description and Business Overview

Table 90. GPI Anatomicals Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 91. GPI Anatomicals Pathological Lung Models Product

Table 92. GPI Anatomicals Recent Developments/Updates

Table 93. Emulate Company Information

Table 94. Emulate Description and Business Overview

Table 95. Emulate Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 96. Emulate Pathological Lung Models Product

Table 97. Emulate Recent Developments/Updates

Table 98. Insphero Company Information

Table 99. Insphero Description and Business Overview

Table 100. Insphero Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 101. Insphero Pathological Lung Models Product

Table 102. Insphero Recent Developments/Updates

Table 103. MatTek Corporation Company Information

Table 104. MatTek Corporation Description and Business Overview

Table 105. MatTek Corporation Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 106. MatTek Corporation Pathological Lung Models Product

Table 107. MatTek Corporation Recent Developments/Updates

Table 108. TissUse Company Information

Table 109. TissUse Description and Business Overview

Table 110. TissUse Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 111. TissUse Pathological Lung Models Product

Table 112. TissUse Recent Developments/Updates

Table 113. CN Bio Innovations Company Information

Table 114. CN Bio Innovations Description and Business Overview

Table 115. CN Bio Innovations Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 116. CN Bio Innovations Pathological Lung Models Product

Table 117. CN Bio Innovations Recent Developments/Updates

Table 118. Eisco Labs Company Information

Table 119. Eisco Labs Description and Business Overview

Table 120. Eisco Labs Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 121. Eisco Labs Pathological Lung Models Product

Table 122. Eisco Labs Recent Developments/Updates

Table 123. Axis Scientific Company Information

Table 124. Axis Scientific Description and Business Overview

Table 125. Axis Scientific Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 126. Axis Scientific Pathological Lung Models Product

Table 127. Axis Scientific Recent Developments/Updates

Table 128. HeineScientific Company Information

Table 129. HeineScientific Description and Business Overview

Table 130. HeineScientific Pathological Lung Models Sales (K Units), Revenue (US$ Million), Price (K Units) and Gross Margin (2020-2025)

Table 131. HeineScientific Pathological Lung Models Product

Table 132. HeineScientific Recent Developments/Updates

Table 133. Key Raw Materials Lists

Table 134. Raw Materials Key Suppliers Lists

Table 135. Pathological Lung Models Distributors List

Table 136. Pathological Lung Models Customers List

Table 137. Pathological Lung Models Market Trends

Table 138. Pathological Lung Models Market Drivers

Table 139. Pathological Lung Models Market Challenges

Table 140. Pathological Lung Models Market Restraints

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

Table 144. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pathological Lung Models

Figure 2. Global Pathological Lung Models Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pathological Lung Models Market Share by Type: 2024 & 2031

Figure 4. Silicone Models Product Picture

Figure 5. Biocomposite Material Models Product Picture

Figure 6. Others Product Picture

Figure 7. Global Pathological Lung Models Market Value by Disease Type, (US$ Million) & (2020-2031)

Figure 8. Global Pathological Lung Models Market Share by Disease Type: 2024 VS 2031

Figure 9. Chronic Diseases Product Picture

Figure 10. Oncology Product Picture

Figure 11. Others Product Picture

Figure 12. Global Pathological Lung Models Market Value by Detail Level, (US$ Million) & (2020-2031)

Figure 13. Global Pathological Lung Models Market Share by Detail Level: 2024 VS 2031

Figure 14. Low Fidelity Product Picture

Figure 15. High Fidelity Product Picture

Figure 16. Global Pathological Lung Models Market Value by Use, (US$ Million) & (2020-2031)

Figure 17. Global Pathological Lung Models Market Share by Use: 2024 VS 2031

Figure 18. Teaching Product Picture

Figure 19. Clinical Drills Product Picture

Figure 20. Global Pathological Lung Models Market Value by Application (2020-2031) & (US$ Million)

Figure 21. Global Pathological Lung Models Market Share by Application: 2024 & 2031

Figure 22. Hospitals

Figure 23. Specialist Clinics

Figure 24. Others

Figure 25. Global Pathological Lung Models Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 26. Global Pathological Lung Models Market Size (2020-2031) & (US$ Million)

Figure 27. Global Pathological Lung Models Sales (2020-2031) & (K Units)

Figure 28. Global Pathological Lung Models Average Price (K Units) & (2020-2031)

Figure 29. Pathological Lung Models Report Years Considered

Figure 30. Pathological Lung Models Sales Share by Manufacturers in 2024

Figure 31. Global Pathological Lung Models Revenue Share by Manufacturers in 2024

Figure 32. Global 5 and 10 Largest Pathological Lung Models Players: Market Share by Revenue in Pathological Lung Models in 2024

Figure 33. Pathological Lung Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 34. Global Pathological Lung Models Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 35. North America Pathological Lung Models Sales Market Share by Country (2020-2031)

Figure 36. North America Pathological Lung Models Revenue Market Share by Country (2020-2031)

Figure 37. United States Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Canada Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Europe Pathological Lung Models Sales Market Share by Country (2020-2031)

Figure 40. Europe Pathological Lung Models Revenue Market Share by Country (2020-2031)

Figure 41. Germany Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. France Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. U.K. Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Italy Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Russia Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Asia Pacific Pathological Lung Models Sales Market Share by Region (2020-2031)

Figure 47. Asia Pacific Pathological Lung Models Revenue Market Share by Region (2020-2031)

Figure 48. China Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Japan Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. South Korea Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. India Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Australia Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. China Taiwan Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Latin America Pathological Lung Models Sales Market Share by Country (2020-2031)

Figure 56. Latin America Pathological Lung Models Revenue Market Share by Country (2020-2031)

Figure 57. Mexico Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Brazil Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Argentina Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Colombia Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 61. Middle East and Africa Pathological Lung Models Sales Market Share by Country (2020-2031)

Figure 62. Middle East and Africa Pathological Lung Models Revenue Market Share by Country (2020-2031)

Figure 63. Turkey Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 64. Saudi Arabia Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 65. UAE Pathological Lung Models Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 66. Global Sales Market Share of Pathological Lung Models by Type (2020-2031)

Figure 67. Global Revenue Market Share of Pathological Lung Models by Type (2020-2031)

Figure 68. Global Pathological Lung Models Price (K Units) by Type (2020-2031)

Figure 69. Global Sales Market Share of Pathological Lung Models by Application (2020-2031)

Figure 70. Global Revenue Market Share of Pathological Lung Models by Application (2020-2031)

Figure 71. Global Pathological Lung Models Price (K Units) by Application (2020-2031)

Figure 72. Pathological Lung Models Value Chain

Figure 73. Channels of Distribution (Direct Vs Distribution)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37F12574

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J20209

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8O12834

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36J12622

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions